192 related articles for article (PubMed ID: 38357988)
1. JNK3 inhibitors as promising pharmaceuticals with neuroprotective properties.
Wu Y; Zhao Y; Guan Z; Esmaeili S; Xiao Z; Kuriakose D
Cell Adh Migr; 2024 Dec; 18(1):1-11. PubMed ID: 38357988
[TBL] [Abstract][Full Text] [Related]
2. Piceatannol improved cerebral blood flow and attenuated JNK3 and mitochondrial apoptotic pathway in a global ischemic model to produce neuroprotection.
Rajan RK; Kumar RP; Ramanathan M
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):479-496. PubMed ID: 37470802
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms.
de Lemos L; Junyent F; Camins A; Castro-Torres RD; Folch J; Olloquequi J; Beas-Zarate C; Verdaguer E; Auladell C
Mol Neurobiol; 2018 May; 55(5):4437-4452. PubMed ID: 28664455
[TBL] [Abstract][Full Text] [Related]
4. Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay.
Rajan RK; Ramanathan M
J Comput Aided Mol Des; 2020 Jun; 34(6):671-682. PubMed ID: 32040807
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury.
Pirianov G; Brywe KG; Mallard C; Edwards AD; Flavell RA; Hagberg H; Mehmet H
J Cereb Blood Flow Metab; 2007 May; 27(5):1022-32. PubMed ID: 17063149
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Potent and Selective JNK3 Inhibitor with Neuroprotective Effect Against Amyloid β-Induced Neurotoxicity in Primary Rat Neurons.
Jun J; Baek J; Yang S; Moon H; Kim H; Cho H; Hah JM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681742
[TBL] [Abstract][Full Text] [Related]
7. Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.
Dou X; Huang H; Li Y; Jiang L; Wang Y; Jin H; Jiao N; Zhang L; Zhang L; Liu Z
J Med Chem; 2019 Jul; 62(14):6645-6664. PubMed ID: 31268308
[TBL] [Abstract][Full Text] [Related]
8. Lack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acid.
Junyent F; de Lemos L; Verdaguer E; Pallàs M; Folch J; Beas-Zárate C; Camins A; Auladell C
Neuropathol Appl Neurobiol; 2012 Jun; 38(4):311-21. PubMed ID: 21883373
[TBL] [Abstract][Full Text] [Related]
9. JNK3 as a therapeutic target for neurodegenerative diseases.
Antoniou X; Falconi M; Di Marino D; Borsello T
J Alzheimers Dis; 2011; 24(4):633-42. PubMed ID: 21321401
[TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-1 protects spinal cord neurons from hydrogen peroxide-induced apoptosis via suppression of Cdc42/MLK3/MKK7/JNK3 signaling.
Wang S; Zhang T; Yang Z; Lin J; Cai B; Ke Q; Lan W; Shi J; Wu S; Lin W
Apoptosis; 2017 Mar; 22(3):449-462. PubMed ID: 27864650
[TBL] [Abstract][Full Text] [Related]
11. Colocalization and Interaction Study of Neuronal JNK3, JIP1, and β-Arrestin2 Together with PSD95.
Musi CA; Marchini G; Giani A; Tomaselli G; Priori EC; Colnaghi L; Borsello T
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456931
[TBL] [Abstract][Full Text] [Related]
12. The structure-based optimization of 3-substituted indolin-2-one derivatives as potent and isoform-selective c-Jun N-terminal kinase 3 (JNK3) inhibitors and biological evaluation.
Li Z; Zhu G; Liu X; Gao T; Fang F; Dou X; Li Y; Zheng R; Jin H; Zhang L; Liu Z; Zhang L
Eur J Med Chem; 2023 Mar; 250():115167. PubMed ID: 36764123
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease.
Jun J; Yang S; Lee J; Moon H; Kim J; Jung H; Im D; Oh Y; Jang M; Cho H; Baek J; Kim H; Kang D; Bae H; Tak C; Hwang K; Kwon H; Kim H; Hah JM
Eur J Med Chem; 2023 Jan; 245(Pt 1):114894. PubMed ID: 36343411
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease.
Shuai W; Bu F; Zhu Y; Wu Y; Xiao H; Pan X; Zhang J; Sun Q; Wang G; Ouyang L
J Med Chem; 2023 Jan; 66(2):1273-1300. PubMed ID: 36649216
[TBL] [Abstract][Full Text] [Related]
15. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.
Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD
Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652
[TBL] [Abstract][Full Text] [Related]
16. The potential role of HO-1 in regulating the MLK3-MKK7-JNK3 module scaffolded by JIP1 during cerebral ischemia/reperfusion in rats.
Song YJ; Dai CX; Li M; Cui MM; Ding X; Zhao XF; Wang CL; Li ZL; Guo MY; Fu YY; Wen XR; Qi DS; Wang YL
Behav Brain Res; 2019 Feb; 359():528-535. PubMed ID: 30412737
[TBL] [Abstract][Full Text] [Related]
17. Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment.
de Lemos L; Junyent F; Verdaguer E; Folch J; Romero R; Pallàs M; Ferrer I; Auladell C; Camins A
J Neurochem; 2010 Sep; 114(5):1315-22. PubMed ID: 20534003
[TBL] [Abstract][Full Text] [Related]
18. Targeting JNK3 for the treatment of neurodegenerative disorders.
Resnick L; Fennell M
Drug Discov Today; 2004 Nov; 9(21):932-9. PubMed ID: 15501728
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold.
Graczyk PP; Khan A; Bhatia GS; Palmer V; Medland D; Numata H; Oinuma H; Catchick J; Dunne A; Ellis M; Smales C; Whitfield J; Neame SJ; Shah B; Wilton D; Morgan L; Patel T; Chung R; Desmond H; Staddon JM; Sato N; Inoue A
Bioorg Med Chem Lett; 2005 Nov; 15(21):4666-70. PubMed ID: 16153829
[TBL] [Abstract][Full Text] [Related]
20. JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases.
Musi CA; Agrò G; Santarella F; Iervasi E; Borsello T
Cells; 2020 Sep; 9(10):. PubMed ID: 32998477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
